Search Results

Omipalisib 10 mg  | 99.16%

TargetMol

GSK2126458 is a small-molecule pyridylsulfonamide inhibitor of phosphatidylinositol 3-kinase (PI3K) with potential antineoplastic activity.

More Information Supplier Page

Atglistatin 25 mg  | 99.81%

TargetMol

Atglistatin is a highly effective, specific and competitive ATGL inhibitor with an IC50 of ~0.7 μM for inhibition of lipolysis in vitro, and no toxicity when the concentration up to 50 μM.

More Information Supplier Page

Atglistatin 50 mg  | 99.81%

TargetMol

Atglistatin is a highly effective, specific and competitive ATGL inhibitor with an IC50 of ~0.7 μM for inhibition of lipolysis in vitro, and no toxicity when the concentration up to 50 μM.

More Information Supplier Page

Kobe0065 50 mg  | 100.00%

TargetMol

Kobe0065 is a novel and effective small-molecule compound inhibiting Ras–Raf interaction by SBDD; shows potent activity to competitively inhibit the binding of H-Ras·GTP to c-Raf-1 RBD with a Ki value of 46 ± 13 μM.

More Information Supplier Page